|
all
Aug 28, 2008 17:25:34 GMT -5
Post by lilsissy on Aug 28, 2008 17:25:34 GMT -5
Bannany,
hopping over to
it
Jennifer
|
|
|
all
Aug 29, 2008 8:47:31 GMT -5
Post by godsgrace on Aug 29, 2008 8:47:31 GMT -5
sis
found this
There are 200 species of Mycoplasma. Most are innocuous and do no harm; only four or five are pathogenic. Mycoplasma fermentans (incognitus strain) probably comes from the nucleus of the Brucella bacterium. This disease agent is not a bacterium and not a virus; it is a mutated form of the Brucella bacterium, combined with a visna virus, from which the mycoplasma is extracted.
hope it helps
gg
|
|
|
all
Aug 29, 2008 13:04:11 GMT -5
Post by godsgrace on Aug 29, 2008 13:04:11 GMT -5
moving moving moving
keep those threads moving
rawhide
|
|
|
all
Aug 30, 2008 4:51:02 GMT -5
Post by Jill on Aug 30, 2008 4:51:02 GMT -5
Gracie, N-acetylglucosamine and N-acetylmuramic acid are these they ingredient's in Mycoplasma? lilsissy, Here is the patent for Mycoplasma Fermentans incognitus tinyurl.com/ll5woExcerpt; Mycoplasma is a genus of cell wall-less sterol-requiring, catalase-negative pathogens commonly found in the respiratory and urogenital tracts of man and other animals. The cells of Mycoplasma are typically non-motile and pleomorphic, ranging from spherical, ovoid or pear-shaped to branched filamentous forms. Filaments are the typical forms in young cultures under optimal conditions, which subsequently transform into chains of coccoid cells end Excerpt: SUMMARY OF INVENTION The present invention relates to a novel strain of the mycoplasma M. fermentans which has been isolated from Kaposi's sarcoma of a patient with AIDS. This novel strain of mycoplasama has been designated the incognitus strain of M. fermentans or M. fermentans incognitus. The invention further relates to the use of this incognitus strain of M. fermentans as well as other strains of M. fermentans with homologous antigenic determinants for the detection of specific antibodies in sera of human patients and animals, and for vaccines against mycoplasmas. The invention also relates to antibodies, including monoclonal antibodies, to M. fermentans incognitus and to homologous antigenic determinants of M. fermentans and their use in detecting M. fermentans incognitus antigens in the infected tissue of human patients and animals. The invention further relates to sequencing the DNA of the M. fermentans incognitus and the manufacture of DNA probes based on such sequencing and homologous sequences of M. fermentans for use in the direct detection of the unique DNA sequences in the tissues of human patients and animals. end excerpt
|
|